<- Go Home

Mayne Pharma Group Limited

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women’s Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third-party customers. It also distributes specialty pharmaceutical products in the dermatology, women’s health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Market Cap

AUD 216.1M

Volume

563.4K

Cash and Equivalents

AUD 67.3M

EBITDA

AUD 26.8M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

AUD 255.0M

Profit Margin

62.63%

52 Week High

AUD 6.50

52 Week Low

AUD 2.04

Dividend

N/A

Price / Book Value

0.61

Price / Earnings

-2.56

Price / Tangible Book Value

-1.47

Enterprise Value

AUD 191.1M

Enterprise Value / EBITDA

6.32

Operating Income

-AUD 38.2M

Return on Equity

20.58%

Return on Assets

-2.30

Cash and Short Term Investments

AUD 67.4M

Debt

AUD 42.5M

Equity

AUD 352.7M

Revenue

AUD 407.1M

Unlevered FCF

AUD 6.0M

Sector

Pharmaceuticals

Category

N/A

Company Stock Pitches